![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1675780
À̽ÄÇü ¾à¹°Àü´Þ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø : Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)Implantable Drug Delivery Devices Market Size, Share, Trends and Forecast by Product Type, Technology, Application, End User, and Region, 2025-2033 |
À̽ÄÇü ¾à¹°Àü´Þ ±â±â ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 152¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö 275¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ̸ç, 2025-2033³â CAGRÀº 6.47%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÇöÀç ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, 2024³â¿¡´Â 40.7% ÀÌ»óÀÇ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¸¸¼ºÁúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡, À̽ÄÇü ÀåÄ¡ÀÇ ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü µîÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.
À̽ÄÇü ¾à¹°Àü´Þ ±â±â´Â ü³»¿¡ À̽ÄÇÏ¿© Àå±â°£¿¡ °ÉÃÄ ¾à¹°À» Áö¼ÓÀûÀ¸·Î ¹æÃâÇÒ ¼ö ÀÖ´Â ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ ±¸Á¶¿¡´Â ÀúÀå¼Ò ¶Ç´Â ¾à¹° ÇÔÀ¯ ±¸È¹, ¹æÃâ ¸ÞÄ¿´ÏÁò, ¾à¹° ¼öÁØ ¶Ç´Â »ý¸®Àû ÆÄ¶ó¹ÌÅ͸¦ ¸ð´ÏÅ͸µÇÏ°í ½Ç½Ã°£À¸·Î Çǵå¹éÀ» Á¦°øÇÏ´Â ¼¾¼ µî ¸î °¡Áö ÁÖ¿ä ±¸¼º¿ä¼Ò°¡ Æ÷ÇԵ˴ϴÙ. À̽ÄÇü ¾à¹°Àü´Þ ±â±â´Â Ç÷·ù ³» ¾à¹° ³óµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ°í °æ±¸ ¾à¹°¿¡ ¼ö¹ÝµÇ´Â ÇÇÅ©¿Í °ñÂ¥±â¸¦ ÇÇÇÒ ¼ö ÀÖ´Â µî ±âÁ¸ ¾à¹° Åõ¿© ¹æ½Ä¿¡ ºñÇØ ¸¹Àº ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. À̸¦ ÅëÇØ ÃÖÀûÀÇ Ä¡·á ¼öÁØÀ» º¸ÀåÇϰí ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ÀåÄ¡´Â ƯÁ¤ °£°ÝÀ¸·Î ¾à¹°À» ¹æÃâÇϵµ·Ï ÇÁ·Î±×·¡¹ÖÇÒ ¼ö Àֱ⠶§¹®¿¡ ºó¹øÇÑ Åõ¿©ÀÇ Çʿ伺À» ÁÙ¿© ȯÀÚÀÇ ÆíÀǼºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ, À̽ÄÇü ¾à¹°Àü´Þ ±â±â´Â ±¹¼ÒÀû ¾à¹°Àü´ÞÀ» °¡´ÉÇÏ°Ô ÇÏ¿© Àü½Å ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈÇϰí Ä¡·á È¿°ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ´Ù¾çÇÑ À¯ÇüÀÇ À̽ÄÇü ¾à¹°Àü´Þ ±â±â°¡ ÀÌ¿ë °¡´ÉÇϸç, ±× Áß¿¡´Â ¸ðÅÍ ±¸µ¿ ¸ÞÄ¿´ÏÁòÀ» ÀÌ¿ëÇÏ¿© Àú¼öÁö¿¡¼ ¾à¹°À» Á¦¾îµÈ ¼Óµµ·Î ¹Ð¾î³»´Â À̽ÄÇü ÆßÇÁµµ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
¼¼°è À̽ÄÇü ¾à¹°Àü´Þ ±â±â ½ÃÀåÀº ÁÖ·Î ¾Ï, ´ç´¢º´, ½ÉÇ÷°üÁúȯ µî ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡ µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¸¸¼ºÁúȯ¿¡ Ãë¾àÇÑ ³ë·É Àα¸ÀÇ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ýºÐÇØ¼º ¹× ÇÁ·Î±×·¥ °¡´ÉÇÑ ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ °³¹ß°ú °°Àº À̽ÄÇü ÀåÄ¡ÀÇ ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü°ú Àå±âÀûÀÎ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, ÀÇ·á ºñ¿ë Àý°¨¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÇ °¡¿ë¼ºÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó °¢±¹ Á¤ºÎ´Â ÷´Ü ÀÇ·á ±â¼úÀ» ÃËÁøÇϱâ À§ÇÑ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃëÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Âü½ÅÇϰí Çõ½ÅÀûÀÎ À̽ÄÇü ¾à¹°Àü´Þ ±â±â¸¦ µµÀÔÇϱâ À§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿ÀÇ È°¼ºÈµµ ½ÃÀå °³Ã´ÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ À̽ÄÇü ¾à¹°Àü´Þ ±â±âÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¸ÂÃãÇü ÀÇ·á¿Í Ç¥Àû ¾à¹°Àü´Þ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
The global implantable drug delivery devices market size was valued at USD 15.24 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 27.58 Billion by 2033, exhibiting a CAGR of 6.47% during 2025-2033. North America currently dominates the market, holding a significant market share of over 40.7% in 2024. The increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, the growing geriatric population susceptible to chronic disorders, and rapid technological advancements in implantable devices are some of the key factors driving the market.
Implantable drug delivery devices are implanted within the body to enable the sustained release of drugs over an extended period. The construction of these devices involves several key components, including a reservoir or a drug-containing compartment, a release mechanism, and sensors to monitor drug levels or physiological parameters, providing real-time feedback. Implantable drug delivery devices offer numerous advantages over conventional drug administration methods, such as maintaining a constant drug concentration in the bloodstream and avoiding the peaks and troughs associated with oral medications. This ensures optimal therapeutic levels and improves patient compliance. Furthermore, these devices can be programmed to release drugs at specific intervals, reducing the need for frequent dosing and improving convenience for patients. Additionally, implantable drug delivery devices enable localized drug delivery, minimizing systemic side effects and enhancing the efficacy of treatment. Currently, there are various types of implantable drug delivery devices available, including implantable pump, which utilizes a motor-driven mechanism to push the drug out of the reservoir at a controlled rate.
The global implantable drug delivery devices market is primarily accelerated by various factors, including the escalating prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Moreover, the rising demand for minimally invasive procedures and the growing geriatric population, which is more susceptible to chronic illnesses, are driving the market growth. Additionally, rapid technological advancements in implantable devices, such as the development of biodegradable and programmable drug delivery systems, and the escalating demand for long-term therapeutic solutions are fueling the market growth. Besides this, the escalating need to reduce healthcare costs and the availability of favorable reimbursement policies are bolstering the market growth. In line with this, governments of various nations are undertaking initiatives to promote advanced healthcare technologies, which, in turn, is propelling the market growth. The burgeoning research and development (R&D) activities aimed at introducing novel and innovative implantable drug delivery devices are also driving market expansion. Other factors, such as the growing awareness about the benefits of implantable drug delivery devices and enhancing focus on personalized medicine and targeted drug delivery, are contributing to the market growth.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.